antipsychotic expert panel.jpg

HONG KONG CHAPTER

Antipsychotic Panel

Chairman: Dr. Michael Ming Cheuk WONG
Moderator: Prof Ki-Yan MAK
Members:

Dr. Yat-Wo Eric CHEUNG
Dr. Roger Man-Kin NG
Dr. Gregory Kai-Lok MAK
Dr. Timothy YEUNG
Dr. David Tai-Wai WONG
Dr. Albert K. K. CHUNG
Dr. Che-Kin LEE

Dr. LAM Chun

Dr. Gloria CHAN

Dr. Ka Lok TAM

Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong

Michael M. C. Wong, Albert K. K. Chung, Timothy M. H. Yeung, David T. W. Wong, C. K. Lee, Eric Lai,
Gloria F. Y. Chan, Gregory K. L. Mak, Jessica O. Y. Wong, Roger M. K. Ng, K. L. Tam and K. Y. Mak
Asian Association of Neuropsychopharmacology​​

Abstract
 

Aripiprazole, a dopamine partial agonist, is a second-generation anti-psychotic that is widely used for the treatment of schizophrenia and other psychotic disorders. A group of psychiatric experts in Hong Kong developed a set of consensus statements, aiming to facilitate the understanding of clinical properties and usages of aripiprazole among local physicians. Of note, because aripiprazole long-acting injectable has been available locally not long before the establishment of the consensus panel, which limited the discussion on its use in the local context, the consensus statements were focused primarilyon oral aripiprazole. To draft the consensus statements, the panellists discussed the published evidence and their clinical experience regarding aripiprazole in a series of meetings based on several areas. At the final meeting, each drafted statement was voted on anonymously by all panellists based on its practicability of recommendation in Hong Kong. A set of consensus statements on the characteristics and clinical use of aripiprazole was established and accepted by the panel. These statements serve to provide a practical reference for physicians in Hong Kong, and possibly other parts of the Asia-Pacific region, on the use of aripiprazole in people with schizophrenia spectrum disorders and other psychotic problems.

Internal Medicine Journal (2020) 50 (Suppl. 3): 6–14. © 2020 Royal Australasian College of Physicians

https://doi.org/10.1111/imj.14896

Consensus statements on aripiprazole once-monthly injectable for Hong Kong

Michael Ming-Cheuk Wong, Ka-Lok Tam, Eric Yat-Wo Cheung, Chun Lam, Timothy Ming-Hong Yeung, Gloria Fong-Yeung Chan, Ki-Yan Mak

Asian Journal of Psychiatry Volume 54, December 2020, 102394  © 2020 Elsevier B.V. All rights reserved.

https://doi.org/10.1016/j.ajp.2020.102394